119 related articles for article (PubMed ID: 21902786)
1. Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina.
Lee SG; Lee CG; Yun IH; Hur DY; Yang JW; Kim HW
Clin Exp Ophthalmol; 2012; 40(1):e47-57. PubMed ID: 21902786
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes.
Lee SG; Kim JL; Lee HK; Ryu GW; Hur DY; Yun IH; Yang JW; Kim HW
Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):389-97. PubMed ID: 20821229
[TBL] [Abstract][Full Text] [Related]
3. Enalapril alters expression of key growth factors in experimental diabetic retinopathy.
Kim HW; Kim JL; Lee HK; Hur DY; Yun IH; Kim SD
Curr Eye Res; 2009 Nov; 34(11):976-87. PubMed ID: 19958114
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.
Kan E; Alici Ö; Kan EK; Ayar A
Int Ophthalmol; 2017 Dec; 37(6):1269-1278. PubMed ID: 27848046
[TBL] [Abstract][Full Text] [Related]
5. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats.
Ohashi H; Takagi H; Koyama S; Oh H; Watanabe D; Antonetti DA; Matsubara T; Nagai K; Arai H; Kita T; Honda Y
Mol Vis; 2004 Aug; 10():608-17. PubMed ID: 15354084
[TBL] [Abstract][Full Text] [Related]
6. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
7. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.
Lin J; Bierhaus A; Bugert P; Dietrich N; Feng Y; Vom Hagen F; Nawroth P; Brownlee M; Hammes HP
Diabetologia; 2006 May; 49(5):1089-96. PubMed ID: 16520919
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.
Obrosova IG; Minchenko AG; Marinescu V; Fathallah L; Kennedy A; Stockert CM; Frank RN; Stevens MJ
Diabetologia; 2001 Sep; 44(9):1102-10. PubMed ID: 11596663
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
12. Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
Wang Q; Pfister F; Dorn-Beineke A; vom Hagen F; Lin J; Feng Y; Hammes HP
Diabetologia; 2010 Jun; 53(6):1227-38. PubMed ID: 20339831
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
[TBL] [Abstract][Full Text] [Related]
15. Early lipoic acid intake protects retina of diabetic mice.
Johnsen-Soriano S; Garcia-Pous M; Arnal E; Sancho-Tello M; Garcia-Delpech S; Miranda M; Bosch-Morell F; Diaz-Llopis M; Navea A; Romero FJ
Free Radic Res; 2008 Jul; 42(7):613-7. PubMed ID: 18608516
[TBL] [Abstract][Full Text] [Related]
16. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
18. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities.
Dene BA; Maritim AC; Sanders RA; Watkins JB
J Ocul Pharmacol Ther; 2005 Feb; 21(1):28-35. PubMed ID: 15718825
[TBL] [Abstract][Full Text] [Related]
19. Lipoic acid in animal models and clinical use in diabetic retinopathy.
Nebbioso M; Pranno F; Pescosolido N
Expert Opin Pharmacother; 2013 Sep; 14(13):1829-38. PubMed ID: 23790257
[TBL] [Abstract][Full Text] [Related]
20. Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys.
Sadi G; Eryilmaz N; Tütüncüoğlu E; Cingir Ş; Güray T
Diabetes Metab Res Rev; 2012 Mar; 28(3):228-35. PubMed ID: 22057777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
